Dianthus Therapeutics (DNTH) Total Liabilities (2017 - 2025)

Dianthus Therapeutics' Total Liabilities history runs 9 years deep, the most recent figure standing at $37.5 million for Q4 2025.

• On a quarterly basis, Total Liabilities rose 74.27% year-over-year to $37.5 million in Q4 2025; TTM through Dec 2025 was $37.5 million, a 74.27% increase from a year earlier, with the FY2025 full-year figure at $37.5 million, up 74.27% from the prior year.
• Total Liabilities climbed to $37.5 million in Q4 2025 per DNTH's latest filing, from $31.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $43.2 million in Q1 2022 and bottomed at $4.0 million in Q2 2023.
• The 5-year median for Total Liabilities is $16.9 million (2021), against an average of $20.2 million.
• Across the five-year window, Total Liabilities surged 177.6% in 2022 and sank 89.77% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $17.3 million in 2021, then tumbled by 45.23% to $9.5 million in 2022, then advanced by 11.43% to $10.5 million in 2023, then jumped by 104.38% to $21.5 million in 2024, then surged by 74.27% to $37.5 million in 2025.
• Per Business Quant, the three latest DNTH Total Liabilities figures stand at $37.5 million (Q4 2025), $31.0 million (Q3 2025), and $23.0 million (Q2 2025).